Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and YoungAdults With Relapsed/Refractory Acute Myeloid Leukemia. This evidence concerns the gene CD33 and acute myeloid leukemia.